Skip to main content
. 2013 Feb 15;8(2):e57016. doi: 10.1371/journal.pone.0057016

Table 1. Urine and serum analyses and body weight.

Controls w4 Cisplatin 4w Controls 9w Cisplatin 9w
Body weight (g) 375 ± 37 305 ± 17 a 406 ± 26 358 ± 37 b
Serum Creatinine (mg/dl) 0.30 ± 0.07 0.42 ± 0.04 a 0.27 ± 0.03 0.54 ± 0.13 b
Serum Mg2+ (mg/dl) 2.60 ± 0.40 2.71 ± 0.24 2.55 ± 0.34 2.90 ± 0.32
Serum Na+ (meq/l) 143.13 ± 3.21 147.37 ± 5.57 146.00 ± 6.47 146.50 ± 4.35
Serum K+ (meq/l) 5.66 ± 1.80 5.51 ± 0.61 5.51 ± 0.33 5.27 ± 0.90
FE Mg2+ (%) 9.23 ± 4.52 32.56 ± 21.50 a,b 9.06 ± 3.08 20.15 ± 8.60
FE Na+ (%) 0.19 ± 0.11 0.18 ± 0.15 0.11 ± 0.06 0.24 ± 0.20

Data are presented in 4 groups: control animals receiving vehicle only, cisplatin-treated animals (2.5 mg/kg/w during 3 weeks) at 4 and 9 weeks after treatment with vehicle or cisplatin. Data are presented as means ± SD. Statistics were performed using generalized linear models. ap<0.05 versus controls at 4 weeks, bp<0.05 versus controls at 9 weeks.